REGENXBIO (RGNX) News Today $9.76 -0.64 (-6.15%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$9.85 +0.09 (+0.96%) As of 05/5/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period PDT Partners LLC Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)PDT Partners LLC purchased a new stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 63,015 shares of the biotechnology company's stock,May 4 at 5:16 AM | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by CANADA LIFE ASSURANCE CoCANADA LIFE ASSURANCE Co trimmed its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 84.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,649 shares of the biotechnology company's stMay 3 at 4:01 AM | marketbeat.comLegal & General Group Plc Lowers Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Legal & General Group Plc lowered its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 63.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,823 shares of the biotechnology company's sMay 3 at 3:29 AM | marketbeat.comAdage Capital Partners GP L.L.C. Buys Shares of 500,000 REGENXBIO Inc. (NASDAQ:RGNX)Adage Capital Partners GP L.L.C. bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 500,000 shares of the biotechnMay 2, 2025 | marketbeat.comREGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational HighlightsApril 30, 2025 | prnewswire.comRegenxbio Stock Short Interest Report | NASDAQ:RGNX | BenzingaApril 29, 2025 | benzinga.comRenaissance Technologies LLC Takes $2.10 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)Renaissance Technologies LLC acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 271,300 shares of the biotechnology company's stock, valuedApril 28, 2025 | marketbeat.comQuantessence Capital LLC Takes $270,000 Position in REGENXBIO Inc. (NASDAQ:RGNX)Quantessence Capital LLC acquired a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 34,888 shares of the biotechnology company's stock, valued at approximately $270,000. Quantessence CapApril 25, 2025 | marketbeat.com88,148 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Bought by Walleye Capital LLCWalleye Capital LLC bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 88,148 shares of the biotechnology company's stock, valued at approximately $681April 25, 2025 | marketbeat.com332,814 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Purchased by Voss Capital LPVoss Capital LP acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 332,814 shares of the biotechnology company's stock, valued at approximatApril 23, 2025 | marketbeat.comJump Financial LLC Grows Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Jump Financial LLC increased its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 144.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,708 shares of the biotechnology company'sApril 22, 2025 | marketbeat.comQ2 Earnings Estimate for REGENXBIO Issued By Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of REGENXBIO in a research report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will earn ($1.49) pApril 20, 2025 | marketbeat.comQ1 Earnings Estimate for REGENXBIO Issued By Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of REGENXBIO in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar expects that the biotechnology company will post earnings of $0.65 pApril 19, 2025 | marketbeat.comXTX Topco Ltd Has $836,000 Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)XTX Topco Ltd raised its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 720.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,120 shares of the biotechnology company's stock afterApril 19, 2025 | marketbeat.comVanguard Group Inc. Sells 1,383,039 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Vanguard Group Inc. lessened its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 31.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,985,952 shares of the biotechnology company's stock after selling 1,38April 17, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from BrokeragesShares of REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buyApril 17, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP lessened its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 44.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 105,668 shares of the biotechnology company's stock after selling 83,4April 13, 2025 | marketbeat.comTrexquant Investment LP Makes New $1.16 Million Investment in REGENXBIO Inc. (NASDAQ:RGNX)Trexquant Investment LP purchased a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 150,022 shares of the biotechnology company'sApril 13, 2025 | marketbeat.comNorges Bank Takes $3.47 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)Norges Bank purchased a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 449,400 shares of the biotechnology company's stock, valued at approximately $3,474,000. Norges Bank owned aApril 13, 2025 | marketbeat.comJPMorgan Chase & Co. Acquires 1,659,206 Shares of REGENXBIO Inc. (NASDAQ:RGNX)JPMorgan Chase & Co. grew its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 67.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,136,517 shares of the biotechnology company's stock after acquApril 9, 2025 | marketbeat.comRaymond James Financial Inc. Invests $568,000 in REGENXBIO Inc. (NASDAQ:RGNX)Raymond James Financial Inc. acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 73,510 shares of the biotechnology company's stoApril 9, 2025 | marketbeat.comHow another firm's FDA approval could mean a big win for Denali TherapeuticsApril 2, 2025 | bizjournals.comChardan Capital Brokers Cut Earnings Estimates for REGENXBIOREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Research analysts at Chardan Capital cut their FY2025 earnings estimates for shares of REGENXBIO in a note issued to investors on Monday, March 24th. Chardan Capital analyst D. Gataulin now expects that the biotechnology company will post earnings perMarch 28, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. cut its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 16.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 349,730 shares of the biotechnologMarch 28, 2025 | marketbeat.com5 Reasons To Buy Regenxbio Right NowMarch 26, 2025 | seekingalpha.comBank of New York Mellon Corp Sells 159,253 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Bank of New York Mellon Corp trimmed its position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 49.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 161,136 shares of the biotechnology company's stock after selling 159,253 shares during the periodMarch 24, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by BrokeragesREGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1March 22, 2025 | marketbeat.comREGENXBIO: New Interim Data Reinforces Potential Of RGX-202 - Quick FactsMarch 21, 2025 | nasdaq.comREGENXBIO (NASDAQ:RGNX) Earns "Buy" Rating from Chardan CapitalChardan Capital restated a "buy" rating and set a $52.00 price target on shares of REGENXBIO in a research note on Thursday.March 21, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for REGENXBIO Q1 Earnings?REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - HC Wainwright upped their Q1 2025 earnings estimates for shares of REGENXBIO in a research note issued on Monday, March 17th. HC Wainwright analyst Y. Chen now anticipates that the biotechnology company will earn ($1.21) per share for the quarter, up fMarch 20, 2025 | marketbeat.comRegenxbio reports data from Phase I/II portion of the Affinity Duchenne trialMarch 19, 2025 | msn.comREGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPYMarch 19, 2025 | prnewswire.comBarclays Keeps Their Buy Rating on RegenXBio (RGNX)March 18, 2025 | markets.businessinsider.comREGENXBIO (NASDAQ:RGNX) Given New $34.00 Price Target at HC WainwrightHC Wainwright decreased their price objective on shares of REGENXBIO from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday.March 18, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Is About To Turn The CornerMarch 17, 2025 | finance.yahoo.comRegenxbio price target lowered to $34 from $36 at H.C. WainwrightMarch 17, 2025 | markets.businessinsider.comREGENXBIO Earnings Results: $RGNX Reports Quarterly EarningsMarch 15, 2025 | nasdaq.comREGENXBIO Inc. (NASDAQ:RGNX) Q4 2024 Earnings Call TranscriptMarch 15, 2025 | msn.comREGENXBIO (NASDAQ:RGNX) Price Target Raised to $24.00Morgan Stanley increased their price target on shares of REGENXBIO from $22.00 to $24.00 and gave the company an "overweight" rating in a report on Friday.March 15, 2025 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Earns Buy Rating from Chardan CapitalChardan Capital reissued a "buy" rating and issued a $52.00 target price on shares of REGENXBIO in a research report on Friday.March 15, 2025 | marketbeat.comREGENXBIO Earnings Call Highlights Strategic ProgressMarch 14, 2025 | tipranks.comREGENXBIO (NASDAQ:RGNX) Releases Earnings Results, Beats Expectations By $0.18 EPSREGENXBIO (NASDAQ:RGNX - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported ($1.01) EPS for the quarter, topping analysts' consensus estimates of ($1.19) by $0.18. REGENXBIO had a negative net margin of 283.19% and a negative return on equity of 70.65%.March 14, 2025 | marketbeat.comRegenxbio at Barclays Healthcare Conference: Strategic Updates and PartnershipsMarch 14, 2025 | investing.comStifel Nicolaus Keeps Their Buy Rating on RegenXBio (RGNX)March 14, 2025 | markets.businessinsider.comRegenXBio (RGNX) Gets a Buy from Bank of America SecuritiesMarch 14, 2025 | markets.businessinsider.comRegenxbio reports Q4 EPS ($1.01), consensus ($1.08)March 14, 2025 | markets.businessinsider.comREGENXBIO Inc. (RGNX) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | seekingalpha.comREGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational UpdatesMarch 13, 2025 | prnewswire.comREGENXBIO Announces Presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceMarch 10, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Rhumbline AdvisersRhumbline Advisers lessened its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 35.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,269 shares of the biotechnology company's stock after selliMarch 8, 2025 | marketbeat.com Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address RGNX Media Mentions By Week RGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼1.420.72▲Average Medical News Sentiment RGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼64▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLPG News IDYA News ARQT News TVTX News APGE News AGIO News HRMY News EWTX News IRON News INDV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RGNX Stock Free RGNX Stock Alerts